{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T21:09:47Z","timestamp":1791407387393,"version":"4.3.3"},"reference-count":27,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2003,11,1]],"date-time":"2003-11-01T00:00:00Z","timestamp":1067644800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2003,11,1]],"date-time":"2003-11-01T00:00:00Z","timestamp":1067644800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ard.eular.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of the Rheumatic Diseases"],"published-print":{"date-parts":[[2003,11]]},"DOI":"10.1136\/ard.62.11.1088","type":"journal-article","created":{"date-parts":[[2003,10,28]],"date-time":"2003-10-28T18:51:57Z","timestamp":1067367117000},"page":"1088-1093","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":609,"title":["Prevalence and outcome in systemic sclerosis associated pulmonary arterial hypertension: application of a registry approach"],"prefix":"10.1016","volume":"62","author":[{"given":"D","family":"Mukerjee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"St George","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B","family":"Coleiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Knight","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C P","family":"Denton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Davar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C M","family":"Black","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J G","family":"Coghlan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1136\/ard.62.11.1088_bib1","doi-asserted-by":"crossref","unstructured":"Brundage BH. Pulmonary hypertension in collagen vascular disease. In: Fishman A, ed. The pulmonary circulation. Pennsylvania: Philadelphia University, 1990:353\u20138.","DOI":"10.9783\/9781512801736-027"},{"key":"10.1136\/ard.62.11.1088_bib2","doi-asserted-by":"crossref","first-page":"425","DOI":"10.7326\/0003-4819-132-6-200003210-00002","article-title":"Continuous intravenous epoprostanol for pulmonary hypertension due to the scleroderma spectrum of disease. A randomized, controlled trial","volume":"132","author":"Badesch","year":"2000","journal-title":"Ann Intern Med"},{"key":"10.1136\/ard.62.11.1088_bib3","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1016\/S0140-6736(01)06250-X","article-title":"Effects of the dual endothelin-receptor antagonist bosentan in patients with pulmonary hypertension: a randomised placebo-controlled study","volume":"358","author":"Channick","year":"2001","journal-title":"Lancet"},{"key":"10.1136\/ard.62.11.1088_bib4","unstructured":"R Naeije, O Sitbon, H Olchewsky, N Gali\u00e8, G Simonneau. New treatments for pulmonary arterial hypertension. The Working Group on \u201cPulmonary Circulation and Right Ventricular Function.\u201d Newscast. Sweden: XXII ESC Congress, 2001."},{"key":"10.1136\/ard.62.11.1088_bib5","unstructured":"Department Of Health and Human Services Food and Drug Administration Public Health Service Division. Cardio-Renal Drug Products Memorandum March 9, 2001. Non-Approval of NDA 21-272, treprostinol (UT-15) Uniprost: United Therapeutics."},{"key":"10.1136\/ard.62.11.1088_bib6","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1002\/art.1780290409","article-title":"Pulmonary hypertension in the CREST syndrome variant of systemic sclerosis","volume":"29","author":"Stupi","year":"1986","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.62.11.1088_bib7","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1093\/rheumatology\/35.10.989","article-title":"Pulmonary hypertension in systemic sclerosis: an analysis of 17 patients","volume":"35","author":"Koh","year":"1996","journal-title":"Br J Rheumatol"},{"key":"10.1136\/ard.62.11.1088_bib8","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1093\/rheumatology\/36.2.239","article-title":"Comparison of Doppler echocardiography and right heart catheterisation to assess pulmonary hypertension in systemic sclerosis","volume":"36","author":"Denton","year":"1997","journal-title":"Br J Rheumatol"},{"key":"10.1136\/ard.62.11.1088_bib9","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1093\/rheumatology\/40.4.453","article-title":"Pulmonary hypertension in systemic sclerosis: risk factors for progression and consequences for survival","volume":"40","author":"MacGregor","year":"2001","journal-title":"Rheumatology (Oxford)"},{"key":"10.1136\/ard.62.11.1088_bib10","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1136\/thx.54.3.273","article-title":"Treatment of pulmonary hypertension secondary to connective tissue diseases","volume":"54","author":"Sanchez","year":"1999","journal-title":"Thorax"},{"key":"10.1136\/ard.62.11.1088_bib11","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1177\/096120339300200606","article-title":"Pulmonary arterial hypertension responsive to immunosuppressive treatment in SLE","volume":"2","author":"Morelli","year":"1993","journal-title":"Lupus"},{"key":"10.1136\/ard.62.11.1088_bib12","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1016\/0002-9149(91)90330-N","article-title":"Acute and long term effects of nifedipine on pulmonary and systemic haemodynamics in patients with pulmonary hypertension associated with diffuse systemic sclerosis, the CREST syndrome and mixed connective tissue disease","volume":"68","author":"Alpert","year":"1991","journal-title":"Am J Cardiol"},{"key":"10.1136\/ard.62.11.1088_bib13","doi-asserted-by":"crossref","first-page":"216","DOI":"10.7326\/0003-4819-107-2-216","article-title":"Primary pulmonary hypertension. A national prospective study","volume":"107","author":"Rich","year":"1987","journal-title":"Ann Intern Med"},{"key":"10.1136\/ard.62.11.1088_bib14","doi-asserted-by":"crossref","first-page":"343","DOI":"10.7326\/0003-4819-115-5-343","article-title":"Survival in patients with primary pulmonary hypertension","volume":"115","author":"D\u2019Alonzo","year":"1991","journal-title":"Ann Intern Med"},{"key":"10.1136\/ard.62.11.1088_bib15","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1161\/01.CIR.89.4.1733","article-title":"Survival in primary pulmonary hypertension","volume":"89","author":"Sandoval","year":"1994","journal-title":"Circulation"},{"key":"10.1136\/ard.62.11.1088_bib16","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1253\/jcj.56.983","article-title":"Echocardiographic evaluation of pulmonary arterial hypertension in patients with systemic and related syndromes","volume":"56","author":"Murata","year":"1992","journal-title":"Jpn Circ J"},{"key":"10.1136\/ard.62.11.1088_bib17","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1378\/chest.110.6.1515","article-title":"Prevalence of pulmonary hypertension in limited and diffuse scleroderma","volume":"110","author":"Battle","year":"1996","journal-title":"Chest"},{"key":"10.1136\/ard.62.11.1088_bib18","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/0002-9343(83)91169-5","article-title":"Prevalence and clinical correlates of pulmonary arterial hypertension in progressive systemic sclerosis","volume":"75","author":"Ungerer","year":"1983","journal-title":"Am J Med"},{"key":"10.1136\/ard.62.11.1088_bib19","doi-asserted-by":"crossref","first-page":"394","DOI":"10.7326\/0003-4819-86-4-394","article-title":"Pulmonary hypertension in the CREST syndrome variant of scleroderma","volume":"86","author":"Salerni","year":"1977","journal-title":"Ann Intern Med"},{"key":"10.1136\/ard.62.11.1088_bib20","first-page":"202","article-title":"Scleroderma: classification, subsets and pathogenesis","volume":"15","author":"LeRoy","year":"1988","journal-title":"Br J Rheumatol"},{"key":"10.1136\/ard.62.11.1088_bib21","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1148\/radiol.2213010158","article-title":"Nonspecific interstitial pneumonia and usual interstitial pneumonia: comparative appearances at and diagnostic accuracy of thin-section CT","volume":"221","author":"MacDonald","year":"2001","journal-title":"Radiology"},{"key":"10.1136\/ard.62.11.1088_bib22","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1056\/NEJM199801293380501","article-title":"Reduction in pulmonary vascular resistance in long-term epoprostenol treatment in primary pulmonary hypertension","volume":"338","author":"McLaughlin","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1136\/ard.62.11.1088_bib23","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1056\/NEJM199207093270203","article-title":"The effects of high doses of calcium channel blockers on survival in primary pulmonary hypertension","volume":"327","author":"Rich","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1136\/ard.62.11.1088_bib24","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1161\/01.CIR.93.3.484","article-title":"Clinical significance of vasodilator response during short-term infusion of prostacyclin in primary pulmonary hypertension","volume":"93","author":"Raffy","year":"1996","journal-title":"Circulation"},{"key":"10.1136\/ard.62.11.1088_bib25","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1161\/01.CIR.95.6.1479","article-title":"Effects of long term infusion of prostacyclin (Epoprostenol) on echocardiographic measures of right ventricular structure and function in primary pulmonary hypertension","volume":"95","year":"1997","journal-title":"Circulation"},{"key":"10.1136\/ard.62.11.1088_bib26","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/S1053-2498(01)00274-1","volume":"20","author":"Homma","year":"2001","journal-title":"J Heart Lung Transplant"},{"key":"10.1136\/ard.62.11.1088_bib27","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1161\/01.CIR.0000029100.82385.58","article-title":"Survival in primary pulmonary hypertension. The impact of epoprostenol treatment","volume":"106","author":"McLaughlin","year":"2002","journal-title":"Circulation"}],"container-title":["Annals of the Rheumatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724087843?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724087843?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ard.62.11.1088","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,20]],"date-time":"2025-01-20T04:56:40Z","timestamp":1737349000000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003496724087843"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,11]]},"references-count":27,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2003,11]]}},"alternative-id":["S0003496724087843"],"URL":"https:\/\/doi.org\/10.1136\/ard.62.11.1088","relation":{},"ISSN":["0003-4967"],"issn-type":[{"value":"0003-4967","type":"print"}],"subject":[],"published":{"date-parts":[[2003,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prevalence and outcome in systemic sclerosis associated pulmonary arterial hypertension: application of a registry approach","name":"articletitle","label":"Article Title"},{"value":"Annals of the Rheumatic Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/ard.62.11.1088","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2003 Copyright 2003 by Annals of the Rheumatic Diseases, Published by Elsevier Inc. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}